Generic Ribavirin Label “Carve Out” Permitted; FDA Denies ICN Petition
Executive Summary
Generic ribavirin labeling can omit information on combination use with PEG-Intron, FDA said
You may also be interested in...
Ribavirin ANDAs Clear FDA; Schering Goes Generic Too
Three Rivers/Par, Sandoz and Schering-Plough are launching their ribavirin generics at a 10% discount to Schering's Rebetol
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011